Skip to main content
Veterinary Medicines

Rabisin vet injektioneste, suspensio

Authorised
  • Rabies virus, strain G52, Inactivated

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Suspenzija za injiciranje
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cat
    • Dog
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • govedo
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cat
    • Dog
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • govedo
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI07AA02
Status dovoljenja:
  • Valid
Authorised in:
  • Finland
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Boehringer Ingelheim Animal Health Denmark A/S
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Boehringer Ingelheim Animal Health France
Pristojni organ:
  • Finnish Medicines Agency
Številka dovoljenja :
  • 13514
Datum spremembe statusa dovoljenja:

Dokumenti

Povzetek glavnih značilnosti zdravila

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Finnish (PDF)
Objavljeno na: 14/06/2023

Navodilo za uporabo

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Finnish (PDF)
Objavljeno na: 14/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."